Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-067504
Filing Date
2008-12-29
Accepted
2008-12-29 14:32:32
Documents
1
Period of Report
2008-12-18

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c78701_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c78701_3x0.xml 3 2123
  Complete submission text file 0001209191-08-067504.txt   4177
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-26301 | Film No.: 081272292
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations